"I wonder if they will be measuring AB40 or AB42 in BetonMace patients? Hope so."

I am confident they will do blood measurements of amyloid beta and other proteomic markers as they did before for post-hoc analysis of Phase 2 clinical samples. However, I am not expecting these measurements or data analysis to be presented this week. They may not have been analyzed yet. But surely, blood samples are banked away for this and many other potential analyses.

BDAZ